Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTB4R | Q15722 | 12/20 | 0.51 |
| ▸ | CKS1B | P61024 | 1/20 | 0.47 |
| ▸ | SKP1 | P63208 | 1/20 | 0.47 |
| ▸ | SKP2 | Q13309 | 1/20 | 0.47 |
| ▸ | CA12 | O43570 | 3/20 | 0.47 |
| ▸ | CA1 | P00915 | 3/20 | 0.47 |
| ▸ | CA2 | P00918 | 3/20 | 0.47 |
| ▸ | CA9 | Q16790 | 3/20 | 0.47 |
| ▸ | SUCNR1 | Q9BXA5 | 3/20 | 0.47 |
| ▸ | STK17B | O94768 | 1/20 | 0.46 |
| ▸ | STK17A | Q9UEE5 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24742223 | 0.79 | CA12 (0.47) | CA12CA1CA2CA9SUCNR1 | |
| SCHEMBL15037007 | 0.78 | CA12 (0.55) | CKS1BSKP1SKP2CA12CA1 | |
| SCHEMBL3531115 | 0.75 | CA12 (0.50) | CKS1BSKP1SKP2CA12CA1 | |
| SCHEMBL22917487 | 0.75 | STK17B (0.49) | CA12CA1CA2CA9STK17B | |
| SCHEMBL24741781 | 0.74 | CA12 (0.50) | CA12CA1CA2CA9SUCNR1 | |
| SCHEMBL16065209 | 0.74 | CA12 (0.50) | CA12CA1CA2CA9STK17B | |
| SCHEMBL16419777 | 0.74 | CA12 (0.54) | CA12CA1CA2CA9SUCNR1 | |
| SCHEMBL24741868 | 0.74 | CKS1B (0.45) | CKS1BSKP1SKP2CA12CA1 | |
| SCHEMBL22917474 | 0.73 | STK17B (0.47) | CA12CA1CA2CA9STK17B | |
| SCHEMBL29911427 | 0.73 | STK17B (0.47) | CA12CA1CA2CA9STK17B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022206888-A1 | CDK2 INHIBITORS AND USE THEREOF | QILU REGOR THERAPEUTICS INC. (CN) | 2022-10-06 | — | — | WO | disclosed |